Fri, June 17, 2022
Thu, June 16, 2022
Wed, June 15, 2022
Tue, June 14, 2022
Mon, June 13, 2022
Sun, June 12, 2022
Fri, June 10, 2022
Thu, June 9, 2022
Wed, June 8, 2022
Tue, June 7, 2022

Andreas Argyrides Initiated (BMRN) at Hold and Held Target at $70 on, Jun 13th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-70-on-jun-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andreas Argyrides of Wedbush, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $70 on, Jun 13th, 2022.

Andreas has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 0 agree with Andreas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andreas


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Monday, June 6th, 2022
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $113 on, Monday, April 25th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $125 on, Thursday, February 24th, 2022

Publication Contributing Sources